As a Partner in L2 Consulting, Leigh Berryman is a serial Chief Executive Officer who has provided leadership to companies in Europe, North America and Asia.  Trained as a toxicologist, he has been involved and directed drug development programs for over 35 years and has led or contributed to over 300 IND applications and first-in-man programs across Europe and North America.  In particular, he was a lead scientist for one of the pioneering recombinant products, rhEPO.  (more…)

As a Partner in L2 Consulting, Louise Bussieres is a serial Chief Financial Officer with over 30 years experience across Europe, North America and Asia.  From 1981 to 1990, she held several positions within the auditing group of KPMG, an international accounting and consulting firm.  In 1990, she joined the Institute Armand-Frappier, an academic research (more…)

As a Partner in L2 Preclinical (Associate Partner L2 Consulting), Dr Gurvinder Singh has over 14 years of experience in Research & Development, Business Development, Operations Management, Project & Program Management and Contract Management with reputed Pharmaceutical/CRO and Healthcare industries based at Singapore, India and US. Dr Singh is a Pharmacy postgraduate (more…)

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management.  Scientifically, L2 has contributed to over 300 new drug clinical trial applications (preclinical), has raised over U$200m in new funding and has been pivotal in closing 6 mid-sized M&A’s in the industry (including execution of full due diligence) with deal values of up to US$50m. (more…)

As an Associate Partner in L2 Consulting, Azadeh Abedian has over 25 years of experience in quality assurance and compliance activities. She earned her MSc degree from McGill University and joined the pharma industry as a research associate and then as the QA manager in a spin-off biopharmaceutical company for a total of over 8 years. She subsequently joined LAB Pre-Clinical in the QA department initially as QA Auditor and thereafter as Head, QAU where she (more…)

As an Associate Partner in L2 Consulting, Dr Anton Kolosov brings close to 20 years of experience in Translational Medical Research and Healthcare industry. In addition to his work in the Pharmaceutical and Consumer Health industry in Singapore (GSK and Pfizer), Anton spent more than 10 years in academia and biotech sectors, leading cutting edge scientific investigations of novel pharmaceutical compounds for the treatment of chronic pain. His work (more…)

As an Associate Partner in L2 Consulting, Creliza (Crel) Sobrepena has over 18 years of experience in quality assurance and compliance activities obtained from contract research and the medical device industry.  She has covered a wide range of regulatory requirements and best-practices across international GXPs, medical device/pharmaceutical regulations, guidance documents, as well as ISO 9001 and ISO 13485.  She has been pivotal in establishing or improving the quality (more…)

As an Associate Partner in L2 Consulting, Dr. Lawrence Mahan comes with an established track record as a successful research scientist and business professional in advanced biomedical technologies. His research spans 25 years including 12 years at the National Institutes of Health as a principal investigator. He has authored more than 100 published articles (more…)

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management.  Scientifically, L2 has contributed to over 300 new drug clinical trial applications (preclinical), has raised over U$200m in new funding and has been pivotal in closing 6 mid-sized M&A’s in the industry (including execution of full due diligence) with deal values of up to US$50m. (more…)

As an Associate Partner in L2 Consulting, Sylvain Mandeville is a dynamic, results oriented professional with over 25 years experience in the pharmaceutical industry including over 18 years of experience in managing regulated laboratories and/or sites. (more…)

As an Associate Partner in L2 Consulting, Robert Gould has over 15 years of experience in laboratory animal research in both rodents and NHPs. His expertise in behavior and neuropharmacology spans surgical procedures, behavioral testing using classic and novel model development for multiple CNS disorders (more…)

As an Associate Partner in L2 Consulting, Dr. Nick Gaspar comes with an established track record as a successful research scientist and leader in biopharmaceutical discovery and development. His industry experience spans 22 years in 5biotech/pharma companies, where he applied his core strengths (more…)

As an Associate Partner in L2 Consulting, David Moddrelle has over 40 years of experience in laboratory animal research with 35 years focused on performing surgical procedures and surgical model development. He is certified through the Academy of Surgical Research in Surgical Research and whose (more…)

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management. Scientifically, L2 has contributed to over 300 new drug clinical trial applications (preclinical) (more…)

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight, and interim management. Scientifically, L2 has contributed to many hundreds of new drug clinical trial applications (preclinical), has raised over U$200m in new funding, and has been pivotal in closing 6 mid-sized M&As in the industry (including the execution of full due diligence) with deal values of up to US$50m. (more…)

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management. Scientifically, L2 has contributed to many hundreds of new drug clinical trial applications (preclinical), has raised over U$200m in new funding and has been pivotal in closing 6 mid-sized M&A’s in the industry (including execution of full due diligence) with deal values of up to US$50m. (more…)

As an Associate Partner in L2 Consulting, Mark comes with an established track of CRO business development leadership spanning more than 20 years.  As Vice President of Business Development for many of the preclinical CROs he has established a firm understand of he strengths and weaknesses of each. He is instrumental is matching the right CRO to the right study set.  He spent over 13 years at The Perkin Elmer Corporation including time at involved the the introduction both PCR and LC/MS/MS technology. Many director of early development and preclinical consultants seek his advice in placing IND and other preclinical programs.

L2 Consulting works with an international client base of life science industries in finance, business planning, M+A, program design, executional oversight and interim management.  Scientifically, L2 has contributed to over 300 new drug clinical trial applications (preclinical), has raised over U$200m in new funding and has been pivotal in closing 6 mid-sized M&A’s in the industry (including execution of full due diligence) with deal values of up to US$50m. (more…)

Dana Nohynek holds senior management and consultancy roles with organizations in Canada, the United States, and Europe, providing regulatory leadership through all
phases of drug development, from entry into first-in-human studies to preparation and conduct of regulatory decision-making trials. (more…)

Patricia M. d’Unienville is the holder of a BSc. (Hons) in microbiology and biochemistry from the University of Cape Town, South Africa. During her postgraduate degree, she worked with the Council for Scientific and Industrial Research on developing a method to cause mutation(s) in an industrial microorganism (Clostridium acetobutilicum) to increase the production of ethanol. (more…)

As an Associate Partner in L2 Consulting, Dr. John S. Sampalis M.SC., PHD., FACE, FAHA is also founder and CEO of JSS Medical Research (founded in 1997).

He is a tenured professor of Surgery and Medicine at McGill University and the University of Montreal. (more…)